Kineta (KA) Delisting to OTC

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. FIX
9. TSCO
10. BE

Go back to Kineta (KA) Delisting to OTC

Kineta, Inc Transitioning from Nasdaq to OTC Markets

September 19, 2024 6:23 PM EDT

Kineta will be trading under the symbol KANT on OTC Pink

Kineta will continue to pursue strategic alternatives as previously announced

TuHURA Biosciences has an exclusivity right and a right of first offer for Kinetas KVA12123 program

The ongoing KVA12123 Phase 1 study is open for new patient enrollment and following those patients previously enrolled.

SEATTLE, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Kineta, Inc., a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer... More